Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non Responder Study in Chronic Hepatitis C Patients
2005-000127-42Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silibinin in hepatitis C virus infection, sponsored by Medical University of Vienna. Primary endpoint: Virologic response at week 24. Started Jan 2005; status: completed.
02
Drugs
silibinin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2005-000127-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000127-42.